SURMOUNT-1 Study Finds Individuals with Obesity Lost up to 22.5% of their Body Weight when Taking Tirzepatide

/PRNewswire/ -- Today, findings from SURMOUNT-1, the first investigational phase 3 trial evaluating the safety and efficacy of tirzepatide for the treatment of...

Related Keywords

New Haven ,Connecticut ,United States ,Spain ,Yale University ,Spanish ,Americans ,American ,Instagram Amdiabetesassn ,Ania Jastreboff ,Aniam Jastreboff ,Daisy Diaz ,Facebook Asociaci ,Yale Stress Center ,Ernestn Morial Convention Center ,American Diabetes Association ,Yale Center ,Us Food Drug Administration ,Facebook American Diabetes Association ,Yale University School Of Medicine ,Linkedin American Diabetes Association ,Yale University School ,Weight Management ,Obesity Prevention ,Drug Administration ,Scientific Sessions ,Convention Center ,New Orleans ,American Diabetes ,Spanish Facebook ,Americana De La Diabetes ,